Journal article
Lessening Organ dysfunction with VITamin C (LOVIT): protocol for a randomized controlled trial
Abstract
BackgroundSepsis is a health problem of global importance; treatments focus on controlling infection and supporting failing organs. Recent clinical research suggests that intravenous vitamin C may decrease mortality in sepsis. We have designed a randomized controlled trial (RCT) to ascertain the effect of vitamin C on the composite endpoint of death or persistent organ dysfunction at 28 days in patients with sepsis.MethodsLOVIT (Lessening Organ …
Authors
Masse M-H; Ménard J; Sprague S; Battista M-C; Cook DJ; Guyatt GH; Heyland DK; Kanji S; Pinto R; Day AG
Journal
Trials, Vol. 21, No. 1,
Publisher
Springer Nature
Publication Date
December 2020
DOI
10.1186/s13063-019-3834-1
ISSN
1468-6708
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
Acute Kidney InjuryAdministration, IntravenousAdultAntioxidantsAscorbic AcidClinical Trials, Phase III as TopicDose-Response Relationship, DrugDrug Therapy, CombinationFemaleHemolysisHospital MortalityHumansHypoglycemiaIntensive Care UnitsMaleMiddle AgedMultiple Organ FailureQuality of LifeSepsisTreatment OutcomeVasoconstrictor Agents